Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment

About this trial

Last updated 2 months ago

Study ID

UP-23-01001(b)

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

35+ Years

All Sexes

Trial Timing

Started 3 months ago

What is this trial about?

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes (T2D).

What are the participation requirements?

Inclusion Criteria

* 35 years of age or older

* Willingness to wear CGM sensor

* Prediabetes by finger prick blood A1C% or fasting glucose

* Centers for Disease Control and Prevention (CDC) prediabetes risk test score of 5 or higher or recent prediabetes diagnosis from physician

Exclusion Criteria

* Diagnosed with any disorder that interferes with glucose

* Influential medical disorder/event affecting ability to participate in study

* Incompatible smartphone device not pairing with Dexcom G6 app

* Currently pregnant

* Previously participated in other Continuous Glucose Monitoring studies

* Having a planned trip outside California in the following 2 months